Test Price
2,800 AEDโ Home Collection Available
๐ Results in 3 to 4 Weeks
NRXN1 Gene Sequencing for Pitt-Hopkins Syndrome โ Genetic Test in Dubai, UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM โ 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The NRXN1 gene sequencing test identifies pathogenic variants associated with Pitt-Hopkins syndrome, a rare genetic disorder characterized by intellectual disability, breathing abnormalities, and distinct facial features. This NGS test provides comprehensive analysis of the entire NRXN1 gene, including detection of deletions via MLPA.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | >99.9% coverage of coding exons, 20X depth | Targeted mutation panel limited |
| Method | NGS with MLPA for deletions | Sanger sequencing of selected exons |
| Speed | 3-4 Weeks | 4-6 Weeks |
Physician Insight & Safety Protocols
Advisory on Medication and Test Preparation
Important Notice
Please consult your physician before stopping any prescribed medications. This test requires no special preparation; however, inform the phlebotomist of any anticoagulant use.
Safety Exclusion Criteria & Emergency Red Flags
- Patient must be clinically stable; active febrile illness may delay sample collection.
- Avoid anticoagulant use within 48 hours before blood draw if possible, unless medically necessary.
- If the patient exhibits signs of acute respiratory distress, seizures, or severe dehydration, seek immediate emergency care instead of scheduling a test.
- This test is not for carrier screening in asymptomatic adults without confirmed family history; consult genetic counseling first.
Patient FAQ & Clinical Guidance
1. What does this test detect?
This NGS sequences the entire NRXN1 gene to identify point mutations, small deletions, or insertions that cause Pitt-Hopkins syndrome, providing a definitive genetic diagnosis.
2. How soon can I get results?
Results are typically available within 3 to 4 weeks; we provide expedited reporting for urgent clinical cases upon request.
3. Is home sample collection safe?
Yes, our DHA-licensed phlebotomists use ISO-certified cold-chain transport, ensuring sample integrity from your doorstep to our CAP-accredited lab.
UAE Regulatory & Data Privacy Adherence
Compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Additionally adheres to Federal Decree-Law No. 4 of 2016 on Medical Liability.
DHA License No.: 1143 | Laboratory Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
Support: WhatsApp & Phone +971 54 548 8731 | 8 AM โ 11 PM daily
Clinical & Logistical Metadata
| Test Name | NRXN1 Gene Sequencing for Pitt-Hopkins Syndrome |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (Home Collection Available via VIP Mobile Phlebotomy) |
| Methodology Used | Next-Generation Sequencing (NGS) with MLPA deletion analysis |
| ICD-10-CM Code | Q87.0 |
| LOINC Code | 21797-6 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["No special preparation required", "Inform phlebotomist of anticoagulant use"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians